Gapping up
In reaction to strong earnings/guidance: BIG +10.2%, SWHC +6.4%, SPLK +4.3%, VEEV +1.4%, ULTA +1.1%
M&A news: AHP +4.1% (will explore strategic alternatives to increase shareholder value, including a possible sale of the company), MU +3.8% (Tsinghua Unigroup's Chairman is said to be meeting with Micron Board members this week to revive its takeover bid, according to reports), SPIL +1.4% (rejects ASX's bid; co and and Hon Hai Precision form strategic alliance through a share exchange), PRGO +1% (Mylan Labs (MYL) announces that shareholders have approved its proposed acquisition of Perrigo; Perrigo comments on Mylan's (MYL) shareholder vote, reaffirms its belief that the offer substantially undervalues it)
Other news: CYTX +20.7% ( lifting premarket on insider transaction), FCX +15.8% ( Carl Icahn discloses 8.46% active stake in 13D; intends to have discussions with management ), HK +11.7% (reduces its long-term debt by ~$548 mln), UAL +6.2% (to replace HSP in the S&P 500), NVTA +5.9% (Baker Bros filed 13D, switching classification from a passive investor to active investor; maintained 20.6% stake), ATVI +5.6% (to replace PLL in the S&P 500), ISNS +4.8% (still checking), AMGN +1.6% (confirmed FDA approval of Repatha (evolocumab) Injection for the treatment of high cholesterol)
Analyst comments: LOGM +1.3% (upgraded to Overweight at Pacific Crest), ASML +0.6% (upgraded to Buy at Berenberg)